Trials / Sponsors / Karus Therapeutics Limited
Karus Therapeutics Limited
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | A Study of Selective HDAC6 Inhibition With KA2507 in Advanced Biliary Tract Cancer Biliary Tract Cancer | Phase 2 | 2020-03-05 |
| Completed | Safety,Tolerability and MTD KA2507 (HDAC6 Inhibitor) in Patients With Solid Tumours Solid Tumor, Adult | Phase 1 | 2017-08-07 |
| Completed | The Safety, Pharmacokinetic and Pharmacodynamic Effect of KA2237 (PI3 Kinase p110β/δ Inhibitor) In B Cell Lymp Lymphoma, B Cell | Phase 1 | 2016-07-01 |